Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary 
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between August 1, 2022, and August 7, 2024, inclusive (the "Class Period").
Shareholders that lost money on Outset Medical, Inc.(OM) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Outset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman
OM Encourages Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESSWIRE / October 9, 2024 / Hagens Berman encourages Outset Medical (NASDAQ:OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical Lawsuit - OM
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Lost Money on Outset Medical, Inc. (OM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Schall Law Firm Encourages Investor Participation In A Case Against Outset Medical, Inc. For Securities Related Infractions
LOS ANGELES, CA / ACCESSWIRE / October 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 1, 2022 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 28, 2024.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical, Inc. Lawsuit - OM
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 9, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between August 1, 2022, and August 7, 2024, inclusive (the "Class Period").
Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders that lost money on Outset Medical, Inc.(OM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 1, 2022 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 28, 2024.
